Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy

Phase 1/2 Completed 46 enrolled Taiwan Liposome Company

NaSingle-groupOpen-labelTreatment

Summary

This is a phase I/IIa, Open label, Dose-escalation Study Investigating the Safety, Tolerability, and Pharmacokinetics of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients with Advanced Malignancy.

Timeline

Start: 2017-06-19
Primary completion: 2020-10-06
Completion: 2020-10-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vinorelbine	Small molecule	—	Intravenous

Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy

Summary

Timeline

Drugs

Indications